Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Research: G Sachs Cuts TP on GDS Holdings Limited to USD49, Raises TP on VNET Group, Inc. to USD16 (AAStocks) +++ GDS Aktie -5,70%

MEDPACE Aktie

 >MEDPACE Aktienkurs 
391.4 EUR    +2.1%    (TradegateBSX)
Ask: 392.4 EUR / 13 Stück
Bid: 377.1 EUR / 14 Stück
Tagesumsatz: 1 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEDPACE Aktie über LYNX handeln
>MEDPACE Performance
1 Woche: +5,3%
1 Monat: +8,2%
3 Monate: +1,4%
6 Monate: -24,9%
1 Jahr: +46,8%
laufendes Jahr: -20,6%
>MEDPACE Aktie
Name:  MEDPACE HOLDINGS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US58506Q1094 / A2APTV
Symbol/ Ticker:  01P (Frankfurt) / MEDP (NASDAQ)
Kürzel:  FRA:01P, ETR:01P, 01P:GR, NASDAQ:MEDP
Index:  -
Webseite:  https://www.medpace.com/
Profil:  Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehen..
>Volltext..
Marktkapitalisierung:  10952.52 Mio. EUR
Unternehmenswert:  10514.35 Mio. EUR
Umsatz:  2297.21 Mio. EUR
EBITDA:  506.93 Mio. EUR
Nettogewinn:  394.89 Mio. EUR
Gewinn je Aktie:  13.93 EUR
Schulden:  125.31 Mio. EUR
Liquide Mittel:  559.82 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.49
Umsatzwachstum:  16.29%
Gewinnwachstum:  3.53%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MEDPACE
Letzte Datenerhebung:  01.06.26
>MEDPACE Kennzahlen
Aktien/ Unternehmen:
Aktien: 28.56 Mio. St.
Frei handelbar: 80.55%
Rückkaufquote: 3.93%
Mitarbeiter: 6200
Umsatz/Mitarb.: 0.35 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 0.75%
Bewertung:
KGV: 27.9
KGV lG: 26.33
KUV: 4.85
KBV: 21.12
PEG-Ratio: 1.32
EV/EBITDA: 20.74
Rentabilität:
Bruttomarge: 28.02%
Gewinnmarge: 17.19%
Operative Marge: 21.02%
Managementeffizenz:
Gesamtkaprendite: 22.87%
Eigenkaprendite: 77.25%
>MEDPACE Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
01.06.26 - 09:54
 Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP (PR Newswire)
 
LOS ANGELES, June 1, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......
01.06.26 - 09:48
 MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, June 1, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities......
29.05.26 - 15:42
 MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to......
28.05.26 - 21:33
 Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, May 28, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO......
27.05.26 - 10:51
 Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP (PR Newswire)
 
LOS ANGELES, May 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......
27.05.26 - 09:48
 MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, May 27, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities......
27.05.26 - 03:27
 MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, May 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead......
26.05.26 - 15:32
 INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MEDP (PR Newswire)
 
SAN DIEGO, May 26, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek......
26.05.26 - 15:06
 MEDP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Medpace Holdings, Inc. Securities Lawsuit - Contact The Gross Law Firm (PR Newswire)
 
NEW YORK, May 26, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
26.05.26 - 12:21
 MEDP Court Notification: Medpace Cancellation Rates and Corresponding 16% Stock Drop Trigger Shareholder Class Action for Securities Fraud (PR Newswire)
 
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026. NEW YORK, May 26, 2026 /PRNewswire/ -- Leading securities law......
22.05.26 - 18:03
 Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU SUFFERED A LOSS ON YOUR......
21.05.26 - 21:12
 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDP (PR Newswire)
 
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......
21.05.26 - 15:12
 MEDP EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to......
21.05.26 - 03:31
 MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, May 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead......
20.05.26 - 18:03
 Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., May 20, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN......
19.05.26 - 12:15
 MEDP Deadline Alert: Medpace Investors with Losses are Notified of the Pending Securities Fraud Class Action Over Alleged Misrepresentations (PR Newswire)
 
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026. NEW YORK, May 19, 2026 /PRNewswire/ -- Leading securities law......
16.05.26 - 01:51
 INVESTOR NOTICE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire)
 
SAN DIEGO, May 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period"), have until Monday, June 8, 2026 to......
15.05.26 - 02:06
 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDP (PR Newswire)
 
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......
14.05.26 - 22:27
 Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, May 14, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO......
14.05.26 - 16:57
 MEDP INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gott kann nichts logisch Unmögliches tun, doch setzt dies seiner Allmacht keine Grenzen. Er kann nichts Absurdes tun oder erfinden. - Leszek Kolakowski
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!